Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DS-1040 Tosylate is an oral active, selective thrombolytic inhibitor with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa, is an orally active, selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa. DS-1040 Tosylate is a fibrinolysis enhancer for thromboembolic diseases[1].
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 945 | 5日内发货 | ||
5 mg | ¥ 1,580 | 5日内发货 | ||
25 mg | ¥ 6,150 | 8-10周 | ||
50 mg | ¥ 7,990 | 8-10周 | ||
100 mg | ¥ 13,700 | 8-10周 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,810 | 5日内发货 |
产品描述 | DS-1040 Tosylate is an oral active, selective thrombolytic inhibitor with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa, is an orally active, selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa. DS-1040 Tosylate is a fibrinolysis enhancer for thromboembolic diseases[1]. |
靶点活性 | TAFIa (rat):8.01 nM , TAFIa (human):5.92 nM |
体外活性 | Ds-1040 Tosylate inhibited human carboxypeptidase N (CPN) in vitro with an IC50 of 3.02 mM. |
体内活性 | DS-1040 Tosylate (0.0005-0.5 mg/kg; IV) significantly reduces the microthrombi index at doses of 0.005 mg/kg and greater. DS1040 (0.016, 0.031, 0.063, 0.13, 0.25, 0.50 mg/kg; i.v.) increases plasma D-dimer levels in a dose-dependent manner in the microthrombosis model. ED50 and EDmax are 122 and 221 nmol/L, respectively. DS-1040 (0.25, 0.5, 1, 2, 4, 8, 16 mg/kg; orally) also increases plasma D-dimer levels. EC50 and ECmax values are 114 and 231 nmol/L, respectively. |
分子量 | 465.61 |
分子式 | C23H35N3O5S |
CAS No. | 1335138-89-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 100 mg/mL (214.77 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O | 1 mM | 2.1477 mL | 10.7386 mL | 21.4772 mL | 53.693 mL |
5 mM | 0.4295 mL | 2.1477 mL | 4.2954 mL | 10.7386 mL | |
10 mM | 0.2148 mL | 1.0739 mL | 2.1477 mL | 5.3693 mL | |
20 mM | 0.1074 mL | 0.5369 mL | 1.0739 mL | 2.6847 mL | |
50 mM | 0.043 mL | 0.2148 mL | 0.4295 mL | 1.0739 mL | |
100 mM | 0.0215 mL | 0.1074 mL | 0.2148 mL | 0.5369 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
DS-1040 Tosylate 1335138-89-0 Others DS1040 Tosylate DS 1040 Tosylate Inhibitor inhibitor inhibit